item1.txt
This transition method allows a Company to apply the new lease accounting standard on adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings.
The Company also elected an accounting policy in which it will not apply the recognition requirements to leases with an initial term of 12 months or less.
Effective June 30, 2019, the first day of adoption, the Company recognized $61.0 million of operating lease right-of-use assets and $65.2 million of operating lease liabilities on its Consolidated Balance Sheet.
When discount rates implicit in leases cannot be readily determined, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments.
Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such option.
The Company elected to combine lease and non-lease components for all asset classes.
In addition, the Company does not apply the recognition requirements to leases with lease terms of 12 months or less.
During the three months ended September 28, 2019 and the year ended June 29, 2019, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
As of September 28, 2019 and June 29, 2019, the fair market value of private company investments amounted to $20.2 million and $20.7 million, respectively.
The aggregate amount of unrealized losses recognized from these investments were $3.6 million and $3.6 million, respectively, as of September 28, 2019 and June 29, 2019.
Unrealized gains (losses) on private company investments were not material during the three months ended September 28, 2019 and September 29, 2018.
In the three months ended September 28, 2019 and September 29, 2018, the Company did not recognize any impairment charges on short-term investments.
As of September 28, 2019 and June 29, 2019, the notional amounts of the forward contracts the Company held to purchase international currencies were $43.0 million and $48.5 million, respectively.
As of September 28, 2019 and June 29, 2019, the notional amounts of the forward contracts the Company held to purchase international currencies were $21.7 million and $19.6 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.1 million, respectively.
forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three months ended September 28, 2019 and September 29, 2018.
On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5%.
On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%.
In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes.


item2.txt
(“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations.
Net revenues were $533.0 million and $638.5 million for the three months ended September 28, 2019 and September 29, 2018, respectively.
These results include net revenues for the three months ended September 29, 2018 that align with our revised end-market categories.
During the three months ended September 28, 2019 and September 29, 2018, approximately 90% and 89% of net revenues, respectively, were derived from customers outside of the United States.
The impact of changes in foreign exchange rates on our revenue and results of operations for the three months ended September 28, 2019 and September 29, 2018 was immaterial.
Our gross margin percentages were 64.4% and 67.4% for the three months ended September 28, 2019 and September 29, 2018, respectively.
Research and development expenses were $109.0 million and $112.7 million for the three months ended September 28, 2019 and September 29, 2018, respectively, which represented 20.4% and 17.7% of net revenues for each respective period.
Selling, general and administrative expenses were $76.1 million and $81.5 million for the three months ended September 28, 2019 and September 29, 2018, respectively, which represented 14.3% and 12.8% of net revenues for each respective period.


item4.txt
Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of September 28, 2019.


part2.txt
The Company’s prior repurchase authorization was cancelled and superseded by this new repurchase authorization.
As of September 28, 2019, the Company had remaining authorization of $1.0 billion for future share repurchases.


